Recursion Pharmaceuticals Inc - Class A — movimiento de fondos (NASDAQ:RXRX)

Financials

Flujo de caja de las actividades operativas -158.61 M-83.52 M-287.78 M-359.17 M-371.81 M -371.81 M Flujo de caja de las actividades de inversión -271.74 M193.25 M-10.23 M260.06 M-16.87 M -16.87 M Flujo de caja de las actividades financieras 458.54 M154.34 M140.13 M304.12 M521.53 M 521.53 M Flujo de caja libre -198.41 M-120.88 M-300.33 M-376.22 M-380.44 M -378.28 M

Recursion Pharmaceuticals Inc - Class A

Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering. The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson.

RXRX

Financials

Recursion Pharmaceuticals Inc - Class A

Noticias

Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors

Evotec T4 2025: fuerte cierre enmascara vientos en contra

Citeline amplía su alianza con Recursion para ensayos clínicos

Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?

Las acciones de Recursion Pharmaceuticals alcanzan mínimos de 52 semanas en 2,98 dólares

Bitcoin Skids, $14 Bil In Options Due; Cathie Wood Raises Cash

El ETF ARK de Cathie Wood vende acciones de Meta y Nvidia, compra Tempus AI

Recursion nombra a Vicki Goodman como directora médica

Recursion Pharmaceuticals, Inc. (RXRX) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Rose the dog might have just heralded the age of programmable medicine — and here are the stocks that benefit

Recursion Pharmaceuticals (RXRX) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down